Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL327528 | 0.89 | MEN1 (0.45) | MEN1KMT2APOLBCA1CA2 | |
| Bromide SCHEMBL1955038 | 0.87 | MEN1 (0.43) | MEN1KMT2APOLBCA1CA2 | |
| SCHEMBL18900831 | 0.77 | MEN1 (0.40) | MEN1KMT2APOLBCA1CA2 | |
| SCHEMBL15353739 | 0.77 | MEN1 (0.36) | MEN1KMT2APOLB | |
| SCHEMBL15353738 | 0.77 | MEN1 (0.40) | MEN1KMT2APOLB | |
| Choline SCHEMBL29284512 | 0.77 | MEN1 (0.52) | MEN1KMT2APOLBLMNACYP3A4 | |
| SCHEMBL327742 | 0.76 | MEN1 (0.45) | MEN1KMT2APOLBCA1CA2 | |
| SCHEMBL27018620 | 0.76 | TSHR (0.50) | MEN1KMT2ALMNACYP3A4SLC5A7 | |
| SCHEMBL299324 | 0.76 | MEN1 (0.45) | MEN1KMT2APOLBLMNACA1 | |
| SCHEMBL27018616 | 0.76 | TSHR (0.50) | MEN1KMT2ALMNACYP3A4SLC5A7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2558525-B2 | THICKENED AMINO ACID SURFACTANT COMPOSITIONS AND METHODS THEREFOR | LUBRIZOL ADVANCED MAT INC (US) | 2018-04-04 | — | — | EP | disclosed |
| US-9931290-B2 | Acrylate copolymer thickeners | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| US-9782609-B2 | Dihydroxyalkyl substituted polygalactomannan, and methods for producing and using the same | HERCULES LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-9724288-B2 | Copolymers useful as rheology modifiers and home and personal care compositions comprising said copolymers | BASF SE (DE) | 2017-08-08 | — | — | US | disclosed |
| EP-2504386-B1 | SURFACTANT-POLYMER BLENDS | LUBRIZOL ADVANCED MAT INC (US) | 2017-03-22 | — | — | EP | disclosed |
| US-9579272-B2 | Alkyl glycoside-based micellar thickeners for surfactant systems | LUBRIZOL ADVANCED MATERIALS, INC. | 2017-02-28 | — | — | US | disclosed |
| US-20160338939-A1 | COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND PERSONAL CARE COMPOSITIONS COMPRISING SAID COPOLYMERS | BASF SE (DE) | 2016-11-24 | — | — | US | disclosed |
| US-9439848-B2 | Copolymers useful as rheology modifiers and home and personal care compositions comprising said copolymers | BASF SE (DE) | 2016-09-13 | — | — | US | disclosed |
| EP-2861204-B1 | ALKYL GLYCOSIDE-BASED MICELLAR THICKENERS FOR SURFACTANT SYSTEMS | LUBRIZOL ADVANCED MAT INC (US) | 2016-08-31 | — | — | EP | disclosed |
| EP-2624812-B1 | ACRYLATE COPOLYMER THICKENERS | LUBRIZOL ADVANCED MAT INC (US) | 2016-08-17 | — | — | EP | disclosed |
| US-20070202069-A1 | Polymers Containing Silicone Copolyol Macromers and Personal Care Compositions Containing Same | LUBRIZOL ADVANCED MATERIALS, INC. | 2007-08-30 | — | — | US | disclosed |
| EP-1729852-A1 | MULTI-PURPOSE POLYMERS, METHODS AND COMPOSITIONS | Noveon, Inc. (US) | 2006-12-13 | — | — | EP | disclosed |
| EP-1581568-B1 | MULTI-PURPOSE POLYMERS, METHODS AND COMPOSITIONS | NOVEON IP HOLDINGS CORP (US) | 2006-07-05 | — | — | EP | disclosed |
| WO-2006033728-A1 | ASSOCIATIVE THICKENERS FOR AQUEOUS SYSTEMS | NOVEON, INC. (US) | 2006-03-30 | — | — | WO | disclosed |
| US-20060039939-A1 | Associative thickeners for aqueous systems | LUBRIZOL ADVANCED MATERIALS, INC. | 2006-02-23 | — | — | US | disclosed |
| WO-2005092276-A1 | MULTI-PURPOSE POLYMERS, METHODS AND COMPOSITIONS | NOVEON, INC. (US) | 2005-10-06 | — | — | WO | disclosed |
| EP-1581568-A2 | MULTI-PURPOSE POLYMERS, METHODS AND COMPOSITIONS | Noveon IP Holdings Corp. (US) | 2005-10-05 | — | — | EP | disclosed |
| US-20040241130-A1 | Multi-purpose polymers, methods and compositions | LUBRIZOL ADVANCED MATERIALS, INC. | 2004-12-02 | — | — | US | disclosed |
| WO-2004024779-A2 | MULTI-PURPOSE CATIONIC AND ASSOCIATIVE POLYMERS AND COMPOSITIONS CONTAINING THEM AND THEIR METHOD OF PREPARATION | NOVEON IP HOLDINGS CORP. (US) | 2004-03-25 | — | — | WO | disclosed |
| US-20040052746-A1 | Multi-purpose polymers, methods and compositions | LUBRIZOL ADVANCED MATERIALS, INC. | 2004-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160338939-A1 | COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND PERSONAL CARE COMPOSITIONS COMPRISING SAID COPOLYMERS | PHLPP1, PHLPP2, F12 | MEN1 546/4885KMT2A 1481/4885POLB 1695/4885 |
| US-20040052746-A1 | Multi-purpose polymers, methods and compositions | PLOD3, PARN, PARG | MEN1 1781/4885KMT2A 1185/4885POLB 944/4885 |
| US-20060039939-A1 | Associative thickeners for aqueous systems | ELL, TAF1, TARBP1 | MEN1 4642/4885KMT2A 1512/4885POLB 1691/4885 |
| US-20040241130-A1 | Multi-purpose polymers, methods and compositions | PLOD3, VCL, PARG | MEN1 2060/4885KMT2A 870/4885POLB 645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.